ONCOLOGIST 润色咨询

ONCOLOGIST

出版年份:1996 年文章数:3179 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2021-04-07 1260965917

    审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0
    偏重的研究方向:乳腺癌;临床研究;个案+综述
    经验分享:2020.6.18投稿,with editor
    2020.7.21 decision in process
    2020.9.10催稿 under review
    中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理
    2021.1.5收到大修的邮件
    2021.2.10文章修回
    2021.3.8第一次催稿未理会
    2021.4.6第二次催稿求理会......

    6

    展开6条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2021-07-04 DyralDeng

    一个月了,还是under review

    6

    展开6条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2021-01-13 牵牛花开

    一个月了,还是with editors😥

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2019-01-15 Xiaocha19957912

    相同遭遇186****7207暂无昵称 2019-01-02 00:00:00 发表:
    请问有没有under review半年的,发邮件也不回复

    186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2023-06-17 watng

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:普外科
    经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2023-07-01 阿曾曾曾曾 来自上海

    变1区了?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2023-05-04 doctor0805 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。
    这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。
    不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!

    8

    展开8条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2023-05-09 ms1000002005931075 来自黑龙江省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肠癌
    经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2019-02-07 s821094_12198728

    审稿速度:2.0
    经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :)

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=954413, encodeId=81a79544134e, content=审稿速度:6.0 | 投稿命中率:25.0 | 审稿费用:90.0 | 版面费用:2500.0<br>偏重的研究方向:乳腺癌;临床研究;个案+综述<br>经验分享:2020.6.18投稿,with editor<br>2020.7.21 decision in process<br>2020.9.10催稿 under review<br>中间2次催稿,均受到编辑回信,under review状态前的时间不断更新,提示编辑确实在处理<br>2021.1.5收到大修的邮件<br>2021.2.10文章修回<br>2021.3.8第一次催稿未理会<br>2021.4.6第二次催稿求理会......, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=23be4781508, createdName=1260965917, createdTime=Wed Apr 07 09:46:15 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996152, encodeId=92d599615209, content=一个月了,还是under review, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210702/b49b637ce90a455bb1e235f83924397b/5bf685e70c6643ba95249595009efb3d.jpg, createdBy=8ef85539728, createdName=DyralDeng, createdTime=Sun Jul 04 18:47:04 CST 2021, time=2021-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916315, encodeId=4ac591631531, content=一个月了,还是with editors😥, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=232, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/03/393d2058bac99c7312cd28b8b0426f23.jpg, createdBy=c7215235406, createdName=牵牛花开, createdTime=Wed Jan 13 18:19:07 CST 2021, time=2021-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=565593, encodeId=84c156559367, content=相同遭遇<span class="quote">186****7207暂无昵称 2019-01-02 00:00:00 发表:<br>请问有没有under review半年的,发邮件也不回复</span>, beContent=186****7207暂无昵称 2019-01-02 00:00:00 发表: 请问有没有under review半年的,发邮件也不回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2a852416931, createdName=Xiaocha19957912, createdTime=Tue Jan 15 00:00:00 CST 2019, time=2019-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2143305, encodeId=e573214330582, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:普外科<br>经验分享:一多月审稿结束,修回。审稿人的建议williamhill asia 没有完全实现,解释了理由,审稿人应该是理解并同意了。第二次修回时,只有编辑提了一些小问题,一个星期内accept。总体感觉很严谨,也相对友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJt9eFezfhFo1XZ4oEVSFHIYMCMWm1wRpVTQ4y1ePTLmA5aS4KlfkY4oj0icfWpJz7sDDiakzyD2ibNw/132, createdBy=98a62105116, createdName=watng, createdTime=Sat Jun 17 11:03:57 CST 2023, time=2023-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2145827, encodeId=359a214582e2e, content=变1区了?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5c5d5201162, createdName=阿曾曾曾曾, createdTime=Sat Jul 01 15:21:08 CST 2023, time=2023-07-01, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2130125, encodeId=60722130125f0, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:oncologist其实不好中,我有两次投稿经历,一次是17年,心得已经发在前面了,另一次是这个。去年11月份,隔离在酒店,师妹的文章发给我,让我改,看着内容写得并不好,随便改改,领导看了后,为了鼓励我用心改,同意让我共通,所以才下功夫改了。花了1一个月时间,到1月初的时候投稿,选了个oncologist,想着试一试。结果第二天就under review了。审了两个月,领导等不及,一直再问,让发个邮件问一问,写了个邮件,发的第二天,人家就给minor review了,一个审稿人提了大概7-8个问题,有的好回答,有的不太好回答,就仔细回答了,给了三周时间,前两周师妹在改,我就没过问,最后一周还是拿来自己改了改,周三是返稿的deadline, 周二返稿,周四accept。<br>这次投稿真的很顺,under review很快,给的返修以来就是minor,然后accept只要两天,也没有语言问题。我都怀疑这篇文章是不是应该投高点了。<br>不过结果挺好的,2周后又中了一篇3.7分的文章,看着挺好的,但是这几篇都不够我出站的,出站必须要唯一一作,且Q2,满足这个有点难,好在3.7分文章接收的同时,另一篇13分的文章也返修了,没说是major 还是minor,只说了we are interested in your paper but not in its current state,希望好运,求好运!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ad11919081, createdName=doctor0805, createdTime=Thu May 04 22:16:11 CST 2023, time=2023-05-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2131172, encodeId=87f321311e20d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肠癌<br>经验分享:请问这个杂志接受以后多久交版面费,大概多久出版见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b715627032, createdName=ms1000002005931075, createdTime=Tue May 09 16:23:21 CST 2023, time=2023-05-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=566545, encodeId=c31856654517, content=审稿速度:2.0<br>经验分享:11月初投稿, 一個禮拜內under review, 12月中收到minor revision, 一月初accept, 算是幸運的 :), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=002b2543176, createdName=s821094_12198728, createdTime=Thu Feb 07 20:22:00 CST 2019, time=2019-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2128981, encodeId=2a9c21289810c, content=慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97ba6513113, createdName=ms2000001677941076, createdTime=Fri Apr 28 12:06:52 CST 2023, time=2023-04-28, status=1, ipAttribution=福建省)]
    2023-04-28 ms2000001677941076 来自福建省

    慎投,小修都给你拒稿,审你的文章就是为了拒你,找了一个不专业的审稿人,提出很多刁钻的角度来批判你的文章,一审论文小修。二审审稿人批判我改的部分的内容不行,可是我是根据审稿人意见修改的。小修修回审稿人九天就看完了,明明马上就可以给decision,硬生生放在编辑那20天,才拒稿。没错,是小修拒稿。总之慎投,浪费时间,浪费精力,审稿人不专业,编辑效率特别慢。

    0

共116条页码: 1/12页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分